Tuttle R L, Knick V C, Stopford C R, Weck C J, Wolberg G
Cancer Res. 1981 Jul;41(7):2633-9.
Although antitumor activity by host cells has been documented in vivo and in vitro, the cellular relationships between these two classes of studies are not clear. Cells capable of causing the regression of solid tumors are generated in lymph nodes draining sites of immunization with Corynebacterium parvum:irradiated P815 mastocytoma admixtures. These cells are active in a 51Cr release assay at a low effector:target ratio producing a characteristic low level of specific 51Cr release which required 24 hr for optimal development. The activity is immunologically specific for the immunizing tumor and is mediated by nonadherent, rapidly dividing (vinblastine-sensitive) cells. They are absent in thymectomized animals and susceptible to alpha-Thy 1.2 antibody and complement. They are present in peritoneal exudates, consistent with the systemic resistance demonstrable in the animal model. The properties and development kinetics of effector cells measured by 51Cr release correlate closely with those of cells showing in vivo activity, supporting the identity of the two populations.
尽管宿主细胞的抗肿瘤活性已在体内和体外得到证实,但这两类研究之间的细胞关系尚不清楚。在用微小棒状杆菌:照射的P815肥大细胞瘤混合物免疫的引流部位淋巴结中产生了能够使实体瘤消退的细胞。这些细胞在低效应细胞:靶细胞比例的51Cr释放试验中具有活性,产生特征性的低水平特异性51Cr释放,最佳发展需要24小时。该活性对免疫肿瘤具有免疫特异性,由非贴壁、快速分裂(对长春碱敏感)的细胞介导。它们在胸腺切除的动物中不存在,并且对α-Thy 1.2抗体和补体敏感。它们存在于腹腔渗出物中,这与动物模型中可证明的全身抗性一致。通过51Cr释放测量的效应细胞的特性和发育动力学与显示体内活性的细胞密切相关,支持这两个群体的同一性。